Cardiovascular Therapeutics Watch Column

Oct 17, 2013

Rick Turner at Quintiles provides an overview of how one of the hottest areas in the treatment of hypertension concerns drug-resistant hypertension. Drug-resistant hypertension is commonly defined as blood pressure (BP) levels above a specified target despite a patient’s adherence to at least three optimally-dosed antihypertensive medications of different classes, including a diuretic. In addition to these requirements, Turner and O’Brien have recently argued that a patient should be on such a regimen for a minimum of three months before the classification is made. The methodology by which BP measurements are made also needs to be given careful consideration in ...

Read More

Innovative Injectable Drug Delivery Systems

Oct 17, 2013

Innovative and complex ideas in the field of polymer injectable drug delivery systems need a capable partner to succeed in realisation. Customised products such as new and innovative injectable drug delivery systems need a wide range of polymer technologies, including injection moulding, extrusion and assembly. Thomas Jakob at Raumedic AG provides examples of innovative injectable drug delivery systems, together with a broad range of know-how and experience of polymer technologies. ...

Read More

Disruptive Change by Linked Data and Semantic Technologies in Healthcare and Life Sciences

Oct 17, 2013

The pharmaceutical industry is undergoing an enormous shift in structure and strategy to reinvent how to bring new drugs to market efficiently. Hans Constandt at Ontoforce explains global drug development strategies – consolidation and partnerships, functional outsourcing relationships, innovation networks, expansion into emerging markets, orphan drugs, translational science, academic alliances and use of public private partnerships (PPP) – all reflect new thinking aimed at achieving higher R&D efficiency and greater return on investment. ...

Read More

Engineering Enhancements in Drug Delivery

Oct 17, 2013

The accelerating pace of technological development is offering new possibilities for manufacturers across the industry, and the need for all sectors to share both knowledge and best practice is crucial. To illustrate just how far some technologies have extended their reach, Mark Jennings at Dawson Shanahan describes how a process once used to forge simple fasteners has recently provided a sophisticated solution for needle-free drug delivery. ...

Read More

Engineering Enhancements in Drug Delivery

Oct 16, 2013

The accelerating pace of technological development is offering new possibilities for manufacturers across the industry, and the need for all sectors to share both knowledge and best practice is crucial. To illustrate just how far some technologies have extended their reach, Mark Jennings at Dawson Shanahan, describes how a process once used to forge simple fasteners has recently provided a sophisticated solution for needle-free drug delivery. ...

Read More